glp-1 and arthritis Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling You Don't Have to Be

The best candidates should have tried diet and exercise to lose weight in the past but failed to get the desired effects

P140/Lupuzor completed Phase IIb trials with positive results and entered Phase III trials for SLE

Scrambled eggs are particularly well-tolerated when appetite is low

Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W et al

ARA-290 (cibinetide) for neuropathy: the clinical trial peptide If BPC-157 represents the strongest preclinical evidence for peptide-based nerve repair, ARA-290 represents the strongest clinical evidence

Integration of computer-assisted bone age assessment with clinical PACS